The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
577 - Hi - I understand that as per Section 6.6iv, an email informing HCPs about 'updated provincial formulary criteria for Drug X' would be considered PAAB exempt (if there were no linkage to therapeutic or promotional claims). Could you provide clarification on whether including a website link to the full formulary list of a province would still be considered exempt? Note that this formulary list contains criteria specific to Drug X.
-
wrote on 20 Nov 2019, 14:16 last edited by
The essence of PAAB code section 6.6iv can be found in section 1.5 now, and states “A message comprised only of the words “now on provincial formulary” (or equivalent) in a manner which is not linked to a therapeutic message in any way”. In addition, the PAAB advisory document “Provincial Formulary Coverage Statements” further states “APS comprised only of “Drug X: Now on OBD formulary” not linked in any way to additional product messages or disease/corporate messages”. As such, a direct link to the coverage criteria for drug X would require review.